Paul Hebeisen,Hugues Matile,Stephan Roever,Matthew Wright,Sannah Zoffmann Jensen
申请号：
US13226521
公开号：
US20120065212A1
申请日:
2011.09.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to compounds of the formulawherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
